anti-aging
-
A landmark study is due to start in the coming months, and if successful it could ultimately revive our immune system in older age and even treat chronic illnesses like autoimmune disease. The Phase 1 trial is aiming to rejuvenate senescent T cells.
-
A company known for its AI image generation has made a surprise pivot – to healthcare. Midjourney says it will deliver a "new form of medical imaging" to map the body, in a day-spa setting, with the first center due to open to the public in 2027.
-
Boo the Whippet was the first patient enrolled in a clinical trial of a life-extending drug for senior dogs. A milestone has been reached in the ongoing trial, with 10-year-old Miniature Dachshund Winston being the thousandth dog to enrol.
-
An 11-year-old Whippet called Boo is the first dog enrolled in a study to trial a drug designed to extend the healthy lifespan of senior dogs of almost all sizes. The researchers are looking for pawticipants across the US to enroll in the study.